SCHEMBL6312401

SCHEMBL6312401

Cc1c(-c2ccccc2)c(N2CCCC2N(C)C)n2c(nc3c(CO)cccc32)c1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 6/20 0.38
RXFP1 Q9HBX9 3/20 0.38
GLA P06280 3/20 0.38
GAA P10253 3/20 0.38
LMNA P02545 3/20 0.37
NPSR1 Q6W5P4 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
RECQL P46063 1/20 0.37
HIF1A Q16665 1/20 0.36
TSHR P16473 3/20 0.35
CASP1 P29466 3/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35
PRF1 P14222 2/20 0.35
HPGD P15428 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.34
NRP1 O14786 3/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311055 0.87 ALDH1A1 (0.36) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6312402 0.85 ALDH1A1 (0.37) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6311404 0.84 ALDH1A1 (0.39) ALDH1A1KDM4ERXFP1GLAGAA
Formic Acid SCHEMBL6310668 0.82 ALDH1A1 (0.47) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6320385 0.80 ALDH1A1 (0.52) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6313026 0.80 KDM4E (0.47) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6310580 0.80 ALDH1A1 (0.47) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6318152 0.79 ALDH1A1 (0.45) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL6311808 0.79 ALDH1A1 (0.45) ALDH1A1KDM4ERXFP1GLAGAA
SCHEMBL5446968 0.79 LMNA (0.35) ALDH1A1KDM4ERXFP1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 ALDH1A1 2550/4885KDM4E 3360/4885RXFP1 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.